IceCure Medical Ltd
ICCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $4 |
| % Growth | 1.9% | 4.7% | -25.4% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $1 | $1 | $1 | $2 |
| % Margin | 44.1% | 40.3% | 46.8% | 53% |
| R&D Expenses | $7 | $8 | $9 | $6 |
| G&A Expenses | $9 | $4 | $6 | $4 |
| SG&A Expenses | $10 | $9 | $9 | $6 |
| Sales & Mktg Exp. | $1 | $4 | $3 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $17 | $18 | $12 |
| Operating Income | -$16 | -$16 | -$17 | -$10 |
| % Margin | -476.9% | -482.4% | -542.6% | -235% |
| Other Income/Exp. Net | $0 | $1 | -$0 | -$0 |
| Pre-Tax Income | -$15 | -$15 | -$17 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15 | -$15 | -$17 | -$10 |
| % Margin | -465.5% | -453.8% | -558.1% | -243.3% |
| EPS | -0.3 | -0.32 | -0.47 | -0.35 |
| % Growth | 6.3% | 31.9% | -34.3% | – |
| EPS Diluted | -0.3 | -0.32 | -0.47 | -0.35 |
| Weighted Avg Shares Out | 51 | 46 | 37 | 29 |
| Weighted Avg Shares Out Dil | 51 | 46 | 37 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15 | -$15 | -$16 | -$10 |
| % Margin | -466.8% | -472.4% | -534.6% | -231.9% |